Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYSATESS: Hypertonic Saline and Terlipressin for Septic Shock
NCT01271114Phase 3Terminated
- Sponsor
- Hospital General Universitario Ciudad Real
- Start
- Jun 2012
- Primary completion
- Dec 2013
- Modality
- Peptides, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised trial of hypertonic saline and terlipressin in septic shock and sepsis (2 arms), sponsored by Hospital General Universitario Ciudad Real. Primary endpoint: Multiple Organ Dysfunction Score. Started Jun 2012; status: terminated.
02
Drugs
hypertonic salineterlipressin
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on NCT01271114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271114.